Vericel Corp risk profile

32 Normal where most of the sector sits

Measured 1 September 2026 from VCEL's filed statements. Recomputed nightly.

32 (Normal), driven by Competitive position at 49, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation42ElevatedVolatileOne-year price volatility — 44.6%
Operating pressure20NormalStableCosts outgrowing revenue — -2.5 percentage points
Cash conversion25NormalEasingCapital spending against operating cash — 0.52x
Leverage and coverage0ContainedEasingNet debt to EBITDA — -0.16x
Competitive position49ElevatedStableOperating-margin gap against peers — +1.0 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Vericel Corp